| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0099 | 0.9 |